Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Early hair loss may indicate prostate issues.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Long-COVID symptoms can last more than a year and change over time.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.